Kir6.2 亚基的酪氨酸磷酸化负向调节心脏 KATP 通道活性

IF 7.5 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Yating Zhi, Bin Yang, Jianyi Huo, Haojie Wang, Bo Yang, Ya-Feng Zhou, Fei Xiao, Hua-Qian Yang
{"title":"Kir6.2 亚基的酪氨酸磷酸化负向调节心脏 KATP 通道活性","authors":"Yating Zhi, Bin Yang, Jianyi Huo, Haojie Wang, Bo Yang, Ya-Feng Zhou, Fei Xiao, Hua-Qian Yang","doi":"10.1007/s00395-025-01108-x","DOIUrl":null,"url":null,"abstract":"<p>The plasma membrane ATP-sensitive potassium (K<sub>ATP</sub>) channel in cardiac myocytes plays a critical role in protecting the heart against ischemic injury. Post-translational modifications regulate K<sub>ATP</sub> channel activity and play a role in cardioprotection. However, the role of tyrosine phosphorylation in K<sub>ATP</sub> channel regulation remains unclear. In this study, we investigated the cardiac K<sub>ATP</sub> channel subtype Kir6.2/SUR2A and demonstrated that a protein tyrosine kinase inhibitor significantly increased the current amplitude through blunting the ATP sensitivity of K<sub>ATP</sub> channels without altering the single-channel current or the channel surface expression. Mutation screening identified Y258 in the Kir6.2 subunit as the tyrosine phosphorylation site of the K<sub>ATP</sub> channel. In cardiomyocytes, K<sub>ATP</sub> channel currents can be reversibly enhanced or weakened by inhibiting the tyrosine kinase epidermal growth factor receptor or the protein tyrosine phosphatase 1B. Furthermore, in a perfused mouse heart model, the inhibitor of epidermal growth factor receptor exhibited a significant cardioprotective effect in a K<sub>ATP</sub> channel dependent manner, indicating the pharmacological potential for treatment of ischemic heart disease.</p>","PeriodicalId":8723,"journal":{"name":"Basic Research in Cardiology","volume":"34 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2025-04-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tyrosine phosphorylation of Kir6.2 subunit negatively regulates cardiac KATP channel activity\",\"authors\":\"Yating Zhi, Bin Yang, Jianyi Huo, Haojie Wang, Bo Yang, Ya-Feng Zhou, Fei Xiao, Hua-Qian Yang\",\"doi\":\"10.1007/s00395-025-01108-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>The plasma membrane ATP-sensitive potassium (K<sub>ATP</sub>) channel in cardiac myocytes plays a critical role in protecting the heart against ischemic injury. Post-translational modifications regulate K<sub>ATP</sub> channel activity and play a role in cardioprotection. However, the role of tyrosine phosphorylation in K<sub>ATP</sub> channel regulation remains unclear. In this study, we investigated the cardiac K<sub>ATP</sub> channel subtype Kir6.2/SUR2A and demonstrated that a protein tyrosine kinase inhibitor significantly increased the current amplitude through blunting the ATP sensitivity of K<sub>ATP</sub> channels without altering the single-channel current or the channel surface expression. Mutation screening identified Y258 in the Kir6.2 subunit as the tyrosine phosphorylation site of the K<sub>ATP</sub> channel. In cardiomyocytes, K<sub>ATP</sub> channel currents can be reversibly enhanced or weakened by inhibiting the tyrosine kinase epidermal growth factor receptor or the protein tyrosine phosphatase 1B. Furthermore, in a perfused mouse heart model, the inhibitor of epidermal growth factor receptor exhibited a significant cardioprotective effect in a K<sub>ATP</sub> channel dependent manner, indicating the pharmacological potential for treatment of ischemic heart disease.</p>\",\"PeriodicalId\":8723,\"journal\":{\"name\":\"Basic Research in Cardiology\",\"volume\":\"34 1\",\"pages\":\"\"},\"PeriodicalIF\":7.5000,\"publicationDate\":\"2025-04-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic Research in Cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s00395-025-01108-x\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00395-025-01108-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

心肌细胞的质膜atp敏感钾(KATP)通道在保护心脏免受缺血性损伤中起关键作用。翻译后修饰调节KATP通道活性并在心脏保护中发挥作用。然而,酪氨酸磷酸化在KATP通道调控中的作用尚不清楚。在本研究中,我们研究了心脏KATP通道Kir6.2/SUR2A亚型,发现一种蛋白酪氨酸激酶抑制剂在不改变单通道电流或通道表面表达的情况下,通过钝化KATP通道的ATP敏感性,显著增加了电流幅度。突变筛选鉴定Kir6.2亚基中的Y258是KATP通道的酪氨酸磷酸化位点。在心肌细胞中,通过抑制酪氨酸激酶表皮生长因子受体或蛋白酪氨酸磷酸酶1B,可以可逆地增强或减弱KATP通道电流。此外,在灌注小鼠心脏模型中,表皮生长因子受体抑制剂以KATP通道依赖的方式表现出显著的心脏保护作用,表明其具有治疗缺血性心脏病的药理潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Tyrosine phosphorylation of Kir6.2 subunit negatively regulates cardiac KATP channel activity

The plasma membrane ATP-sensitive potassium (KATP) channel in cardiac myocytes plays a critical role in protecting the heart against ischemic injury. Post-translational modifications regulate KATP channel activity and play a role in cardioprotection. However, the role of tyrosine phosphorylation in KATP channel regulation remains unclear. In this study, we investigated the cardiac KATP channel subtype Kir6.2/SUR2A and demonstrated that a protein tyrosine kinase inhibitor significantly increased the current amplitude through blunting the ATP sensitivity of KATP channels without altering the single-channel current or the channel surface expression. Mutation screening identified Y258 in the Kir6.2 subunit as the tyrosine phosphorylation site of the KATP channel. In cardiomyocytes, KATP channel currents can be reversibly enhanced or weakened by inhibiting the tyrosine kinase epidermal growth factor receptor or the protein tyrosine phosphatase 1B. Furthermore, in a perfused mouse heart model, the inhibitor of epidermal growth factor receptor exhibited a significant cardioprotective effect in a KATP channel dependent manner, indicating the pharmacological potential for treatment of ischemic heart disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Basic Research in Cardiology
Basic Research in Cardiology 医学-心血管系统
CiteScore
16.30
自引率
5.30%
发文量
54
审稿时长
6-12 weeks
期刊介绍: Basic Research in Cardiology is an international journal for cardiovascular research. It provides a forum for original and review articles related to experimental cardiology that meet its stringent scientific standards. Basic Research in Cardiology regularly receives articles from the fields of - Molecular and Cellular Biology - Biochemistry - Biophysics - Pharmacology - Physiology and Pathology - Clinical Cardiology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信